Research and Markets has announced the addition of the "Infusion Pumps - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, ...

DUBLIN--(BUSINESS WIRE)--The "Global Infusion Pumps Market (2023 Edition): Analysis By Product Type (Volumetric, Ambulatory, Insulin, PCA, Syringe Pumps, Others), By Indication, End Use, By Region, By ...

DUBLIN--(BUSINESS WIRE)--The "Insulin Pens, Syringes, Pumps and Injectors Global Market Opportunities and Strategies to 2030" report has been added to ResearchAndMarkets.com's offering. This report ...

The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 ...

Dr. Cook answers the question: 'Pros of Giving Insulin By Pen/Syringe?' — -- Question:What are the pros and cons of giving insulin by syringe and by pen? Answer:Well the pen-versus-syringe ...

Managing diabetes can be challenging, but technology has made it significantly easier for many people. One such technological advancement is the insulin pump, a device that delivers insulin ...

Please provide your email address to receive an email when new articles are posted on . The FDA expanded the indication for insulin aspart injection 100 U/mL to include use in insulin infusion pumps ...

Every time Vanessa publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Adults and children with type 1 diabetes spend an average of $2,500 a year on out-of-pocket health care expenses, but surprisingly the cost of insulin isn't always the driving force. A University of ...

MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust and autocorrect insulin delivery in ...

The expanded approval was based on data from the phase 3 PRONTO-PUMP-2 trial which evaluated Lyumjev vs Humalog for use in insulin pump therapy in 432 adults with type 1 diabetes. The Food and Drug ...